Moderna begins study of COVID-19 vaccine in kids - Reuters

Moderna Inc has begun dosing patients in a mid-to-late stage study of its COVID-19 vaccine, mRNA-1273, in children aged six months to less than 12 years, the company said on Tuesday. https://www.reuters.com/article/health-coronavirus-moderna-idUSL4N2LE2Q7